FI961378A - Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi - Google Patents

Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi Download PDF

Info

Publication number
FI961378A
FI961378A FI961378A FI961378A FI961378A FI 961378 A FI961378 A FI 961378A FI 961378 A FI961378 A FI 961378A FI 961378 A FI961378 A FI 961378A FI 961378 A FI961378 A FI 961378A
Authority
FI
Finland
Prior art keywords
methyl
ethanesulfonamide
piperidinyl
indole
preparation
Prior art date
Application number
FI961378A
Other languages
English (en)
Swedish (sv)
Other versions
FI961378A0 (fi
FI111162B (fi
Inventor
Philip Blatcher
Malcolm Carter
Roy Hornby
Martin Richard Owen
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI961378A publication Critical patent/FI961378A/fi
Publication of FI961378A0 publication Critical patent/FI961378A0/fi
Application granted granted Critical
Publication of FI111162B publication Critical patent/FI111162B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI961378A 1993-09-29 1996-03-26 Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi FI111162B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9320115 1993-09-29
GB939320115A GB9320115D0 (en) 1993-09-29 1993-09-29 Process
PCT/EP1994/003216 WO1995009166A1 (en) 1993-09-29 1994-09-27 Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-14-indole-5-ethanesulphonamide
EP9403216 1994-09-27

Publications (3)

Publication Number Publication Date
FI961378A true FI961378A (fi) 1996-03-26
FI961378A0 FI961378A0 (fi) 1996-03-26
FI111162B FI111162B (fi) 2003-06-13

Family

ID=10742727

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961378A FI111162B (fi) 1993-09-29 1996-03-26 Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi

Country Status (32)

Country Link
US (2) US5659040A (fi)
EP (1) EP0721453B1 (fi)
JP (1) JP3411284B2 (fi)
CN (2) CN1132509A (fi)
AP (1) AP529A (fi)
AT (1) ATE228124T1 (fi)
AU (1) AU682219B2 (fi)
CA (1) CA2170645C (fi)
CO (1) CO4290351A1 (fi)
CZ (1) CZ287581B6 (fi)
DE (1) DE69431759T2 (fi)
DK (1) DK0721453T3 (fi)
ES (1) ES2187534T3 (fi)
FI (1) FI111162B (fi)
GB (1) GB9320115D0 (fi)
HK (1) HK1004218A1 (fi)
HR (1) HRP940613B1 (fi)
HU (1) HU226828B1 (fi)
IL (1) IL111071A (fi)
IS (1) IS1877B (fi)
MY (1) MY117934A (fi)
NO (1) NO309324B1 (fi)
NZ (1) NZ274159A (fi)
PE (1) PE18195A1 (fi)
PL (1) PL178456B1 (fi)
PT (1) PT721453E (fi)
RU (1) RU2143428C1 (fi)
SG (1) SG49322A1 (fi)
SI (1) SI0721453T1 (fi)
SK (1) SK282234B6 (fi)
WO (1) WO1995009166A1 (fi)
ZA (1) ZA947516B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69918799D1 (de) 1998-01-14 2004-08-26 Uab Res Foundation Birmingham Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
WO2006010078A2 (en) * 2004-07-08 2006-01-26 Dr. Reddy's Laboratories Ltd. Polymorphic form of naratriptan hydrochloride
WO2006010079A2 (en) * 2004-07-08 2006-01-26 Dr. Reddy's Laboratories Ltd. Process for preparing naratriptan hydrochloride
CN1315821C (zh) * 2004-12-16 2007-05-16 上海美通生物科技有限公司 制备n-甲基-3-(1-甲基-4-哌啶基)-1,4-吲哚-5-乙硫胺的改进法
JP2009515833A (ja) * 2005-10-24 2009-04-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 3−ピペリジン−4−イル−インドールorl−1受容体モジュレーター
WO2009118753A2 (en) * 2008-03-07 2009-10-01 Usv Limited Process for preparation of naratriptan hydrochloride
CN101676283A (zh) * 2008-09-17 2010-03-24 北京德众万全药物技术开发有限公司 一种那拉曲坦的制备方法
AU2010284832A1 (en) 2009-08-20 2012-02-09 Cipla Limited A process for the synthesis of naratriptan
CN101792411B (zh) * 2010-03-26 2012-05-30 常州晟永光电材料有限公司 一种合成乙磺酰胺的方法
CN103073484B (zh) * 2013-01-28 2014-10-22 山东诚创医药技术开发有限公司 一种甲哌卡因及其光学对映体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0131327B1 (en) * 1987-08-13 1998-04-17 Glaxo Group Ltd Indole derivatives
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
GB8903036D0 (en) * 1989-02-10 1989-03-30 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
SI0721453T1 (en) 2003-04-30
WO1995009166A1 (en) 1995-04-06
IL111071A (en) 1998-10-30
JPH09502991A (ja) 1997-03-25
PL313740A1 (en) 1996-07-22
DK0721453T3 (da) 2003-03-17
NO309324B1 (no) 2001-01-15
ATE228124T1 (de) 2002-12-15
US5659040A (en) 1997-08-19
CN1332166A (zh) 2002-01-23
NZ274159A (en) 1997-09-22
CZ287581B6 (en) 2000-12-13
IS1877B (is) 2003-06-20
CN1132509A (zh) 1996-10-02
IS4212A (is) 1995-03-30
RU2143428C1 (ru) 1999-12-27
ES2187534T3 (es) 2003-06-16
HRP940613B1 (en) 2003-10-31
ZA947516B (en) 1995-06-12
JP3411284B2 (ja) 2003-05-26
NO961252L (no) 1996-03-28
HUT75642A (en) 1997-05-28
AP529A (en) 1996-09-09
GB9320115D0 (en) 1993-11-17
AP9400676A0 (en) 1994-10-31
CA2170645A1 (en) 1995-04-06
SG49322A1 (en) 1998-05-18
FI961378A0 (fi) 1996-03-26
US5786473A (en) 1998-07-28
DE69431759D1 (de) 2003-01-02
CZ76896A3 (en) 1996-06-12
IL111071A0 (en) 1994-11-28
SK282234B6 (sk) 2001-12-03
AU682219B2 (en) 1997-09-25
HK1004218A1 (en) 1998-11-20
AU7810194A (en) 1995-04-18
CA2170645C (en) 2005-11-15
EP0721453A1 (en) 1996-07-17
PE18195A1 (es) 1995-07-27
CO4290351A1 (es) 1996-04-17
HU226828B1 (en) 2009-11-30
PL178456B1 (pl) 2000-05-31
EP0721453B1 (en) 2002-11-20
NO961252D0 (no) 1996-03-28
SK40696A3 (en) 1996-10-02
DE69431759T2 (de) 2003-07-03
MY117934A (en) 2004-08-30
PT721453E (pt) 2003-03-31
FI111162B (fi) 2003-06-13
HU9600814D0 (en) 1996-05-28
HRP940613A2 (en) 1997-06-30

Similar Documents

Publication Publication Date Title
FI903737A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten pentafluorietyyli-substituoitujen valiini- tai fenyylialaniinijohdannaisten valmistamiseksi
FI960278A (fi) Anataasititaanidioksidin valmistusmenetelmä
FI940769A (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
FI942907A (fi) Menetelmä lipaasin valmistamiseksi
FI961378A (fi) Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi
FI954272A (fi) Menetelmä akryylipiperidiinikarbinolien valmistamiseksi
FI103727B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-amino-4-substioitu-fenyyli-4H-pyrano[3,2-h]kinoliini-3-karbonitriilien valmistamiseksi
FI972065A (fi) Menetelmä N-fosfonometyyliglysiinin valmistamiseksi
FI102270B1 (fi) Menetelmä dieettereiden valmistamiseksi
FI902316A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä
FI942102A0 (fi) Menetelmä alumiinioksaanien valmistamiseksi
FI964229A (fi) Menetelmä doksorubisiinin valmistamiseksi
FI956058A (fi) Menetelmä glutaaridialdehydin valmistamiseksi
NO179244C (no) Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal
NO306065B1 (no) Fremgangsmåte for fremstilling av organoklorsilaner
FI961178A (fi) Menetelmä syklisten cis-1-amino-2-alkanolien valmistamiseksi
FI892144A0 (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
FI940551A0 (fi) Menetelmä fenyylibentsamidijohdannaisten valmistamiseksi
FI943660A (fi) Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi
FI971964A0 (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
FI973341A (fi) Menetelmä organosilaanien valmistamiseksi
FI97725B (fi) Menetelmä diltiatseemin valmistamiseksi
FI951441A (fi) Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi
FI953181A0 (fi) Puriinien valmistusmenetelmä

Legal Events

Date Code Title Description
MM Patent lapsed